Bluejay Diagnostics (BJDX) Profit After Tax (2020 - 2026)

Bluejay Diagnostics (BJDX) has 7 years of Profit After Tax data on file, last reported at -$1.9 million in Q1 2026.

• For the quarter ending Q1 2026, Profit After Tax fell 2.94% year-over-year to -$1.9 million; the trailing twelve-month figure through Mar 2026 stood at -$6.9 million (up 4.83% YoY), and the FY2025 full-year result was -$6.8 million, up 11.26% from the prior year.
• Profit After Tax declined to -$1.9 million in Q1 2026, from -$1.4 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of -$1.4 million in Q4 2025 to a low of -$3.0 million in Q3 2022.
• A 5-year average of -$2.1 million and a median of -$2.0 million in 2022 frame the typical range for Profit After Tax.
• Across the five-year window, Profit After Tax tumbled 936.83% in 2022 and jumped 37.81% in 2024, its largest moves.
• Tracing BJDX's Profit After Tax over 5 years: stood at -$2.4 million in 2022, then grew by 3.5% to -$2.3 million in 2023, then surged by 37.81% to -$1.4 million in 2024, then grew by 0.15% to -$1.4 million in 2025, then tumbled by 34.23% to -$1.9 million in 2026.
• Business Quant data shows BJDX's Profit After Tax at -$1.9 million in Q1 2026, -$1.4 million in Q4 2025, and -$1.6 million in Q3 2025.